GSK215 represents a highly effective and specific PROTAC designed to degrade focal adhesion kinase (FAK). Engineered with a binding affinity for both the VHL E3 ligase and the FAK inhibitor VS-4718, GSK215 facilitates swift and sustained degradation of FAK, resulting in a durable impact on FAK levels and a notable disconnect between pharmacokinetics/pharmacodynamics (PK/PD).
Usually ships within 24 hours.